In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


World View

Navigate through In Vivo features from around the globe. Read more about how the war in Ukraine is impacting pharma, the IRA bill is faring in the US, and how mRNA vaccines are being produced in South Africa. Also check on how companies in the Asia Pacific have been progressing with the Scrip Asia 100 data set of prescription sales from 2021.

APAC As A Clinical Trial Powerhouse

In the last 10 years, APAC has become a hotspot for clinical trials: the region contributed almost 50% of new clinical trial activity globally in 2021.

Big Pharma Rescripts India Playbook

Big pharma appears to be resetting operations in India fueling some concerns of waning interest. In Vivo looks at what the realignment means or doesn’t.

Pandemic Drives China Surge In Asia 100 Sales

Notable new entrants moved into the Asia 100 this year, with growth catalyzed by COVID-19 vaccines.

Korea Readying Itself For New Era Of Digital Therapeutics

Scrip takes a look at the current landscape in the South Korean digital therapeutics sector, where some remaining gaps in regulation and reimbursement are seen but multiple products are now progressing through pivotal local clinical trials.

The Asia 100 ranking is based on Citeline’s analysis of fiscal year 2021 prescription sales data. For more information contact: [email protected].